Writers
Data Analysts
Consultants
Product Developers
Researchers
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 40 /hr
Hire Bailey A.
United States
USD 40 /hr

Freelance Medical Writer with experience in oncology clinical development and precision medicine

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Technical Writing
Research Systematic Literature Review, Secondary Data Collection
Work Experience

PRA Health Sciences

2020 - Present

Eli Lilly and Co

July 2018 - 2020

University of Michigan

March 2016 - July 2018

Education

University of Michigan

September 2014 - April 2016

Certifications

  • Certified Clinical Research Professional

    Society of Clinical Research Associates

    November 2017 - Present

Publications
JOURNAL ARTICLE
(2021). A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors . Investigational new drugs.
(2020). Accrual Trends for Children's Oncology Group Clinical Trials: A Single Center Experience . Journal of pediatric hematology/oncology.
(2020). Clinical Sequencing of High-Grade Undifferentiated Sarcomas: A Case Series and Report of an Aggressive Primary Cardiac Tumor With Multiple Oncogenic Drivers . JCO precision oncology.
(2020). Hepatosplenic αβ T-Cell Lymphoma as Second Malignancy in Young Adult Patient With Previously Undiagnosed Ataxia-Telangiectasia . Journal of pediatric hematology/oncology.
(2020). Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia . Translational pediatrics.
(2019). KRAS mutant tenosynovial giant cell tumor in a pediatric patient: a case report . Translational pediatrics.
(2019). Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia . Journal of pediatric hematology/oncology.
(2019). DICER1 Mutations in the Era of Expanding Integrative Clinical Sequencing in Pediatric Oncology . JCO precision oncology.
(2019). Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib . Cold Spring Harbor molecular case studies.
(2018). CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response . Acta neuropathologica communications.
(2018). Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program . JCO precision oncology.
(2018). Exceptional Response to Cabozantinib in a Patient With Multiply Relapsed Wilms Tumor . JCO precision oncology.
(2018). Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors . JCO precision oncology.
(2018). Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review . Cold Spring Harbor molecular case studies.
(2017). Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors . Translational research : the journal of laboratory and clinical medicine.